TP53
| Official symbol: | TP53 |
| Full name: | tumor protein p53 |
| Location: | |
| Also known as: | LFS1, p53 |
| Entrez ID: | 7157 |
| Ensembl ID: | ENSG00000141510 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 1.12 (Driver) |
|
|
|
| Recurrently deleted in 3 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Recurrently mutated in 24 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 7 |
|
|
| Fusions detected in 5 cancer type(s) |
|
| |
|
|
|
| Functional class: | Transcription factor |
| JensenLab PubMed score: | 54026.30 (Percentile rank: 99.99%) |
| PubTator score: | 35081.83 (Percentile rank: 99.99%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
